SEC Tracker
Get the app

Standard Biotools LAB

Standard BioTools sells Microfluidics to ARCHIMED

Merger communication

Form
425
Filed
Importance
Routine
  1. Agreement to sell Microfluidics business to ARCHIMED
  2. Transaction expected to close in 30 days
  3. ARCHIMED is a healthcare-focused investment firm

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Standard Biotools files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Aquestive Therapeutics AQST public float $292M, Jun 30, 2025
  2. Siga Technologies SIGA public float $302M, Jun 30, 2025
  3. Ocugen OCGN public float $279M, Jun 30, 2025
  4. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  5. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.